News Releases - Achieve Life Sciences

News Releases

Home

Home ivps4 2017-06-16T21:39:52+00:00

News Releases

Month Year

Month Year

Investor Alerts

Jan 6, 2022

Achieve Life Sciences to Present at H.C. Wainwright BIOCONNECT Virtual Conference
Jan 4, 2022

Achieve Life Sciences Announces Completion of Last Subject, Last Follow-Up Visit in Phase 3 ORCA-2 Trial of Cytisinicline for Smoking Cessation
Dec 22, 2021

Achieve Life Sciences Announces $25 Million Loan Facility from Silicon Valley Bank to Fund Cytisinicline Smoking Cessation Clinical Development
Nov 23, 2021

Achieve Life Sciences to Host Key Opinion Leader Panel on Smoking and e-Cigarette Cessation
Nov 22, 2021

Achieve Life Sciences Announces Phase 3 ORCA-2 Trial of Cytisinicline in Smoking Cessation Clears Final Review by Data Safety Monitoring Committee (DSMC)
Nov 9, 2021

Achieve Reports Financial Results for Third Quarter 2021 and Provides Update on Cytisinicline Development
Nov 4, 2021

Achieve Life Sciences Announces Participation in November Investor Conferences
Nov 2, 2021

Achieve Life Sciences Announces FDA Acceptance of IND Application for Cytisinicline’s Second Planned Indication for Nicotine E-cigarette Cessation
Oct 26, 2021

Achieve Life Sciences to Announce Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 9, 2021
Sep 15, 2021

Achieve Life Sciences to Participate in Upcoming Investor Conferences

Show per page

Stock Info